Call For Abstract

Announcement and Call for Abstracts
The deadline for submitting abstracts is 15th January, 2018
Dear Colleagues,
 
The scientific committee of the 1st Middle East Lipid Update Conference has issued a call for abstracts for its Conference on 19-20 April 2018, being held at Rosewood Hotel, Abu Dhabi, UAE, this event will shed the light on the latest advances and best practices in the management of dyslipidemia and cardiovascular risk. The program will cover areas like recent lipid guidelines, interventional lifestyle therapy, up to date drug therapeutic approaches to managing dyslipidemia, and innovative diagnostic techniques in the assessment of atherosclerosis to review of recent Lipid Guidelines.
 
Topics will be delivered by prominent national and international speakers, renowned teaching faculty and thought leading experts from various specialties to encourage exchange of knowledge, experience and best practices in the arena of Clinical Lipidology.
 
The main objective for the conference is to:
  • Raise awareness of Lipids as a major risk factor for cardiovascular disease in the region
  • Explore major causes of dyslipidemia in the population including diet and inheritance
  • Recognize the role of drug therapy in the management of dyslipidemia
  • Review the mechanism of action, pharmacokinetics, and efficacy of available FDA approved drugs for the management of lipid disorders
  • Assess the side effects of lipid-altering drugs to encourage their safe use in cardiovascular disease prevention
  • Describe the appropriate use of lipid-altering drugs in special populations
  • Identify lipid-lowering therapeutic approaches for older adults
  • Describe effective diet and lifestyle strategies for long-term obesity and dyslipidemia management
  • Describe effective diet and lifestyle (exercise, weight management) strategies for the management of dyslipidemia and cardiovascular risk
  • Outline current guidelines on the management and treatment of patients with dyslipidemia
  • Compose a clinical care plan for reducing risk of CVD in patients with dyslipidemia
  • Analyze case studies in lipid management to improve treatment and prevention of cardiovascular disease
  • Analyze lipid cases for health professionals seeing patients with complex disorders
  • Identify the management of dyslipidemia in special populations based on gender, culture, and disease variables
  • Explain how obesity and adiposopathy contribute to the metabolic syndrome and diabetes mellitus
  • Identify management strategies for the cardiometabolic risk factors of the metabolic syndrome
  • Assess the side effects of lipid-altering drugs to encourage their safe use in cardiovascular disease prevention
  • Review clinical trials of lipid-altering drug therapies used in cardiovascular disease prevention
  • Describe combination therapies for the management of complex lipid disorders and residual risk
  • Manage complex dyslipidemia and dyslipidemia in special populations

The scientific committee invites speakers to submit their abstracts on the below key topics.
Epidemiology of CVD
  • CVD: A Global Overview
  • Lipid Metabolism, Disorders and Risk Assessment
  • Lipids Across the Lifetime
  • Lipid Metabolism & Lipoproteins
  • Lipids in Atherosclerosis
  • Lipids Nutrition and Health
  • Biology of Atherosclerosis
  • Familial Hypercholesterolemia
  • Lipid Guidelines: Update
  • Management of Dyslipidemia
  • Statins, Lipids and CVD
  • Ezetimibe, Lipids and CVD
  • PCSK9, Lipids and CVD
  • Fibrates and CVD
  • Non-Drug Treatment of CVD
  • Mediterranean Diet, Lipids and CVD
  • Exercise, Lipids and CVD
  • Food supplements, Lipids and CVD
  • Omega-3 fatty acids, Dyslipidemia and CVD
  • Lipids and Other Diseases
  • Unusual Lipid Disorders
  • NASH and Dyslipidemia
  • Metabolic Syndrome and Dyslipidemia
  • Diabetic Dyslipidemia
  • Lipids and Kidney Disease
  • Myalgia and statins
  • Diabetes and statins
Presentations will be selected based on: relevance, best practices, case studies and completeness of the required information submitted. Participants want real life examples of what works and practical take-away tools/solutions.      
Conference Date(s) and Venue:
Conference Date: 19 - 20 April, 2018  
Venue: Rosewood Hotel, Abu Dhabi, UAE

Abstract Guidelines
All abstracts submitted for presentations (by the 15st January, 2018) will be assessed and prospective speakers will be notified about the results by 31st January, 2018.

Speakers are advised to keep the following guidelines in mind when planning both the abstracts and presentations:

Abstracts must contain original scientific data collected by the author(s). All reports must be based on work that has already been completed. No studies "in progress" will be accepted. The abstracts will be scored on the following criteria:
  • Originality
  • Concept and design
  • Presentation
  • Applicability
  • Other characteristics
Language: All abstracts are to be written in English. The Scientific Committee reserves the right to edit abstracts for grammar and clarity.
 
Submission: All abstracts must be submitted via the Abstract Form which can be accessed at www.menaconference.com this should be limited to a maximum of 250 words and should include the following:
 
Title of abstract
Names and contact details of author(s) {organization, city /country, email, phone numbers, fax numbers and mailing address}. Please indicate the name of the presenter/ clearly and provide the author’s biography with the abstract.
 
The abstract must include the following headings clearly: Purpose, Methods, Results and Conclusions.
Abstract submission will be acknowledged via email. If you do not receive an email within one week of submission or have any additional queries please contact Ms. Andra Mae Email:andra.mae@menaconference.com

Important dates
  • 15th January, 2018– Deadline for submission of abstracts.
  • 31st January, 2018 – Presenters will be notified of acceptance.
 
Important Information
  • All abstracts must be prepared using the abstract submission guidelines.
  • Each presenter may submit a maximum of two abstracts.
  • Each abstract submission must indicate if the material was published or presented in any prior Congress or if it received any awards
  • All presenters will be registered to attend the Conference if abstract is accepted and be present at the time of the Congress.
  • A certificate of appreciation will be given to all the presenters to honor their presentation.
  • Presenters must not use the session as a marketing opportunity for products/equipment
  • Travel (Economy class ticket), accommodation and visa process will be provided to accepted abstracts
 
For further information, please contact Ms. Andra Mae via:
Email:andra.mae@menaconference.com
Phone: +971 2 4919888

Thank you for your interest in presenting at  “1st Middle East Lipid Update Conference”

WE LOOK FORWARD TO RECEIVING YOUR ABSTRACTS
 
Attach Abstract Presentation
Allowed file formats : Pdf .doc . Docx only
* Fields are mandatory.